Table 2 Control reactionsa
The chemistry recently reported by Hodgson and
co-workers best illustrates the potential in that regioselective
ring-opening of the terminal aziridine bearing sulfinyl
functionality using PhMgBr in the presence of CuI would
allow for the installation of the benzyl functionality found in
both amprenivir and saquanivir.9 Switching PhMgBr with
thiophenol, an advanced intermediate used in the preparation
of nelfinavir can be realized. That is, the final steps toward the
preparation of N-protected 3-amino-1,2-epoxide 8 would
include deprotection of the aminodiol using HCl in dioxane,4,9
BOC-protection of the amine, and functional group inter-
conversion of the diol to epoxy functionality.8a,10
Yield
(%)b drc
Entry Sulfonium salt p-acceptor
1
81
61 : 39
d
2
3
4
—
In summary, a number of groups have demonstrated and
refined ingenious approaches toward the preparation of
homochiral carbo- and heterocyclic rings using sulfur ylide
technology. While our approach has several shortcomings in
that the decarboxylative process does not operate well at
or below ambient reaction temperatures, high levels of
diastereocontrol can be achieved. Diastereomeric ratios of
80
72
67 : 33
60 : 40
495
: 5 were obtained when performing methylene
transfers onto imines originating from the D-mannitol and
(S)-(À)-2-methyl-2-propane sulfinamide or ascorbic acid and
(R)-(À)-2-methyl-2-propane sulfinamide. Currently we are
active in examining the source of stereocontrol through
computational studies and applying this technology in the
assembly of materials of biological and medicinal importance.
Results from these studies will be reported in due course.
This work was supported in part by NIGMS (NIH NIGMS
1R15GM085936), NSF (CHE 0514004), and the Camille and
Henry Dreyfus Foundation (TH-06-008).
a
b
See ESIw for reaction details. Isolated chromatographically pure
material. Determined by 1H NMR (crude reaction mixture).
d
c
Inextrictable crude reaction mixture (1H NMR).
Fig. 1 Potential applications.
Notes and references
1 D. C. Forbes, S. R. Amin, C. J. Bean and M. C. Standen, J. Org.
Chem., 2006, 71, 8287.
2 (a) D. C. Forbes, S. V. Bettigeri, S. A. Patrawala, S. C. Pischek and
M. C. Standen, Tetrahedron, 2009, 65, 70; (b) D. C. Forbes,
S. V. Bettigeri, S. R. Amin, C. J. Bean, A. M. Law and
R. A. Stockman, Synth. Commun., in press.
3 D. C. Forbes, M. C. Standen and D. L. Lewis, Org. Lett., 2003, 5,
2283.
4 (a) P. Michel and S. V. Ley, Angew. Chem., Int. Ed., 2002, 41, 3898;
(b) P. Michel and S. V. Ley, Synthesis, 2003, 1598; (c) P. Michel
and S. V. Ley, Synthesis, 2004, 147.
highly discriminating additions onto either butanediacetal-
protected glyceraldehyde 24 or tert-butylsulfinamides such as
those present in a-chloroimines,7 our study which operates at
an elevated reaction temperature when compared to the pre-
vious two mandates both when performing stereoselective
methylene transfers onto butanediacetal-protected chiral
non-racemic sulfinyl imines.
We do believe the stereodiscriminating event is addition
onto the imine and not epimerization of the aziridine. Control
reactions which examined a solution of Cs2CO3 and the
aziridine using imine ent-5 did not result in a change of
diastereomeric ratio even after 10 h at reflux (Table 1,
entry 3). Furthermore, stopping the aziridination reaction
prematurely using imine 4 had the same diastereomeric ratio
as its endpoint of 495 : 5.
Synthesized terminal azirdines, both enantiomeric lines,
starting from imines 4 and ent-4 are interesting examples in
that they present a viable scaffold when considering the
assembly of systems of biological and medicinal significance.
Using as an example the three-carbon building block
N-protected 3-amino-1,2-epoxide 8, which is an intermediate
used in the assembly of many HIV protease inhibitors,8 our
approach serves as a viable alternative toward the preparation
of this advanced intermediate (Fig. 1).
5 (a) J.-P. Cheng, B. Liu and X.-M. Zhang, J. Org. Chem., 1998, 63,
7574; (b) A. W. Johnson and R. T. Amel, Can. J. Chem., 1968, 46, 461.
6 D. Morton, D. Pearson, R. A. Field and R. A. Stockman, Synlett,
2003, 1985.
7 D. M. Hodgson, J. Kloesges and B. Evans, Org. Lett., 2008, 10, 2781.
8 (a) K. Izawa and T. Onishi, Chem. Rev., 2006, 106, 2811;
(b) Y. Honda, S. Katayama, M. Kojima, T. Suzuki,
N. Kishibata and K. Izawa, Org. Biomol. Chem., 2004, 2, 2061;
(c) D. Wang, M. D. Schwinden, L. Radesca, B. Patel,
D. Kronenthal, M.-H. Huang and W. Nugent, J. Org. Chem.,
2004, 69, 1629; (d) B. E. Evans, K. E. Rittle, C. F. Homnick,
J. P. Springer, J. Hirshfield and D. F. Veber, J. Org. Chem., 1985,
50, 4615; (e) P. L. Beaulieu, D. Wernic, J.-S. Duceppe and
Y. Guindon, Tetrahedron Lett., 1995, 36, 3317; (f) M. T. Reetz
and J. Binder, Tetrahedron Lett., 1989, 30, 5425; (g) D. P. Rotella,
Tetrahedron Lett., 1995, 36, 5453.
9 D. M. Hodgson, S. P. Hughes, A. L. Thompson and
T. D. Heightman, Org. Lett., 2008, 10, 3453.
10 B. M. Kim, S. J. Bae, S. M. So, H. T. Yoo, S. K. Chang, J. H. Lee
and J. Kang, Org. Lett., 2001, 3, 2349.
ꢀc
This journal is The Royal Society of Chemistry 2009
1884 | Chem. Commun., 2009, 1882–1884